Translator Disclaimer
1 June 2000 FIELD ANESTHESIA OF WILD ARCTIC FOX (ALOPEX LAGOPUS) CUBS IN THE SWEDISH LAPLAND USING MEDETOMIDINE–KETAMINE–ATIPAMEZOLE
Author Affiliations +
Abstract

A safe and effective anesthetic regime for use in arctic fox (Alopex lagopus) cubs was developed. During July 1996, six free-ranging 6–8-wk-old cubs were captured near their den in Vindelfjallen Nature Reserve, Sweden. Medetomidine and ketamine HCl, followed by atipamezole, were selected for the anesthetic trial because of the well-documented safety and efficacy of this drug combination in a broad range of species. The dosage regimen used was 50 µg/kg medetomidine combined with 2.5 mg/kg ketamine followed by reversal with 250 µg/kg atipamezole. Induction was rapid, with a mean induction time of 1 min and 32 sec (range: 58–150 sec). The cubs were anesthetized for a mean time of 18 ± 5 min (range: 13–25 min). Serially recorded heart rate, respiratory rate, temperature, and pulse oximetry were stable throughout the anesthetic period for all cubs. Anesthetic depth was suitable for safe handling and minor clinical procedures, including venipuncture. Following atipamezole, all cubs were standing within 12 ± 7 min (range: 5–24 min) and fully recovered at 27 ± 5 min (range: 19–36 min). This information will be useful for future captive breeding and management programs involving the endangered arctic fox.

A. Alonso Aguirre, B. Principe, Magnus Tannerfeldt, Anders Angerbjörn, and Torsten Mörner "FIELD ANESTHESIA OF WILD ARCTIC FOX (ALOPEX LAGOPUS) CUBS IN THE SWEDISH LAPLAND USING MEDETOMIDINE–KETAMINE–ATIPAMEZOLE," Journal of Zoo and Wildlife Medicine 31(2), 244-246, (1 June 2000). https://doi.org/10.1638/1042-7260(2000)031[0244:FAOWAF]2.0.CO;2
Received: 1 June 1999; Published: 1 June 2000
JOURNAL ARTICLE
3 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top